Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer
Apatinib, an anti-tumor drug selectively targeting VEGFR2 (Vascular Endothelia Growth Factor Recpetor-2), has been proven effective in Chinese patients with liver cancer. Generally, treatment with apatinib achieves 16.1% of the overall objective remission rate (ORR) and 55.83% of the disease control...
Main Authors: | Hui Xia, Cheng Zhou, Zhaoxia Luo, Ping Zhang, Liping Zhu, Zhao Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.624369/full |
Similar Items
-
Hand-foot skin reaction with sunitinib: A rare case report with review of literature
by: Suchibrata Das, et al.
Published: (2020-01-01) -
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
by: Enxin Wang, et al.
Published: (2019-04-01) -
Falls and Physical Inactivity in Patients with Gastrointestinal Cancer and Hand–Foot Syndrome
by: Hiroko Komatsu, et al.
Published: (2018-01-01) -
Specificity of hand-foot skin reaction induced by multikinase inhibitors: clinical, histological and ultrasound characteristics
by: E. A. Shatokhina, et al.
Published: (2020-07-01) -
The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand–Foot Skin Reaction
by: Shou L, et al.
Published: (2021-01-01)